Park Ha Biological Technology Co., Ltd.

$1.08 ▲ 0.96%
2026-04-21 05:51:00
NCM: BYAH

Explore Park Ha Biological Technology Co., Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$3.54 M
Current Price
$1.08
52W High / Low
$2,074.5 / $0.93
Stock P/E
Book Value
$5.9
Dividend Yield
ROCE
-593.23%
ROE
-8.86%
Face Value
EPS
$-2,069
Exp Qtr EPS
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
41
Beta
Debt / Equity
4.51
Current Ratio
2.92
Quick Ratio
2.88
Forward P/E
Price / Sales
1.33
Enterprise Value
$-2.9 M
EV / EBITDA
0.12
EV / Revenue
-1.15
Rating
None
Target Price
EPS Forecast (FY)

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Operating margin is thin.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Solesence, Inc. $1.22 49.32 $88.29 M 4.35% 10.99% $5.63 / $0.78 $0.25
2. Waldencast plc $1.03 $132.75 M -9.67% -40.33% $3.22 / $0.86 $3.91
3. Spectrum Brands Holdings, Inc. $85.41 18.91 $1.98 B 2.2% 5.23% 5.35% $85.45 / $49.99 $81.52
4. Edgewell Personal Care Company $23.57 $1.1 B 2.55% 6.13% 0.42% $31.04 / $15.88 $31.81
5. Coty Inc. $2.37 $2.06 B 0.64% 5.66% -12.59% $5.34 / $1.95 $4.02
6. Nu Skin Enterprises, Inc. $7.82 2.34 $375.53 M 3.07% 7.96% 22% $14.62 / $5.32 $16.71
7. Interparfums, Inc. $98.01 18.7 $3.15 B 3.26% 21.78% 20.34% $142.61 / $77.21 $27.46

Quarterly Results

Figures shown in M / B

Sales
Operating Profit
Net Profit
EPS in Rs

Profit & Loss

Figures shown in M / B

2025202420232022
Sales2.52 M2.38 M2.46 M1.92 M
Operating Profit-24.15 M0.79 M1.18 M0.2 M
Net Profit-24.36 M0.48 M0.85 M0.19 M
EPS in Rs-8.580.170.30.07

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets5.95 M3.08 M2.26 M2.52 M
Total Liabilities1.96 M1.58 M1.25 M2.37 M
Equity3.99 M1.51 M1.01 M0.15 M
Current Assets5.5 M2.84 M2.18 M2.26 M
Current Liabilities1.88 M1.52 M1.24 M2.37 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF0.09 M0.96 M0.13 M1.44 M
Investing CF-0.57 M-0.51 M1.02 M-1.55 M
Financing CF3.74 M-0.96 M-0.68 M0.67 M
Free CF-0 M0.87 M0.1 M1.43 M
Capex-0.09 M-0.09 M-0.02 M-0.01 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

2024202320222021
Revenue Growth %-3.14%28.12%
Earnings Growth %-43.83%345.4%
Profit Margin %20.09%34.65%9.97%
Operating Margin %33.32%48.01%10.26%
Gross Margin %91.8%87.35%73.47%
EBITDA Margin %34.26%48.86%11.5%

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

No dividend history available.

Stock Splits

DateSplit
2026-02-201:0.02

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund Mutual Fund 0 M $0 M 0% 2026-02-28
Renaissance Technologies, LLC Institutional 0.01 M $0.01 M 0% 2025-12-31
Citadel Advisors Llc Institutional 0 M $0 M 0% 2025-12-31
Xtx Topco Ltd Institutional 0 M $0 M 0% 2025-12-31
Virtu Financial LLC Institutional 0 M $0 M 0% 2025-12-31
Jane Street Group, LLC Institutional 0 M $0 M 0% 2025-12-31
Geode Capital Management, LLC Institutional 0 M $0 M 0% 2025-12-31
Stonex Group Inc. Institutional 0 M $0 M 0% 2025-12-31
Two Sigma Securities, LLC Institutional 0 M $0 M 0% 2025-12-31
Morgan Stanley Institutional 0 M $0 M 0% 2025-12-31
UBS Group AG Institutional 0 M $0 M 2025-12-31